Parnassus Investments
AGN.PRA

Parnassus Investments’s Allergan plc AGN.PRA Stock Holding History

Parnassus Investments’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,900
Closed -$2.52M – 94
2017
Q2 		$2.52M Hold
2,900
– – 0.01% 83
2017
Q1 		$2.46M Hold
2,900
– – 0.01% 78
2016
Q4 		$2.21M Buy
+2,900
New +$2.19M 0.01% 78

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Parnassus Investments's AGN.PRA Position: Q3 2017 in Review

Parnassus Investments sold out of Allergan plc (AGN.PRA) in Q3 2017, closing a stake of 2,900 shares — an estimated $2.52M sold.

Parnassus Investments first reported a position in AGN.PRA in Q4 2016 and held it in 3 quarters. The position peaked at $2.52M in Q2 2017. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2017.

  • Parnassus Investments reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Parnassus Investments sold 2,900 Allergan plc shares in Q3 2017, an estimated $2.52M.
  • Parnassus Investments first reported a position in Allergan plc in Q4 2016 and held it in 3 quarters.
  • Parnassus Investments's Allergan plc position peaked at $2.52M in Q2 2017.
  • 106 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Parnassus Investments's 13F filing for Q3 2017, filed 1 Nov 2017.